<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36920842</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2561-326X</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2023</Year><Month>Apr</Month><Day>18</Day></PubDate></JournalIssue><Title>JMIR formative research</Title><ISOAbbreviation>JMIR Form Res</ISOAbbreviation></Journal><ArticleTitle>Incidence and Characterization of Post-COVID-19 Symptoms in Hospitalized COVID-19 Survivors to Recognize Syndemic Connotations in India: Single-Center Prospective Observational Cohort Study.</ArticleTitle><Pagination><StartPage>e40028</StartPage><MedlinePgn>e40028</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e40028</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/40028</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long COVID, or post-COVID-19 syndrome, is the persistence of signs and symptoms that develop during or after COVID-19 infection for more than 12 weeks and are not explained by an alternative diagnosis. In spite of health care recouping to prepandemic states, the post-COVID-19 state tends to be less recognized from low- and middle-income country settings and holistic therapeutic protocols do not exist. Owing to the syndemic nature of COVID-19, it is important to characterize post-COVID-19 syndrome.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to determine the incidence of post-COVID-19 symptoms in a cohort of inpatients who recovered from COVID-19 from February to July 2021 at a tertiary-care center in South India. In addition, we aimed at comparing the prevalence of post-COVID-19 manifestations in intensive care unit (ICU) and non-ICU patients, assessing the persistence, severity, and characteristics of post-COVID-19 manifestations, and elucidating the risk factors associated with the presence of post-COVID-19 manifestations.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 120 adult patients admitted with COVID-19 in the specified time frame were recruited into the study after providing informed written consent. The cohort included 50 patients requiring intensive care and 70 patients without intensive care. The follow-up was conducted on the second and sixth weeks after discharge with a structured questionnaire. The questionnaire was filled in by the patient/family member of the patient during their visit to the hospital for follow-up at 2 weeks and through telephone follow-up at 6 weeks.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean age of the cohort was 55 years and 55% were men. Only 5% of the cohort had taken the first dose of COVID-19 vaccination. Among the 120 patients, 58.3% had mild COVID-19 and 41.7% had moderate to severe COVID-19 infection. In addition, 60.8% (n=73) of patients had at least one persistent symptom at the sixth week of discharge and 50 (41.7%) patients required intensive care during their inpatient stay. The presence of persistent symptoms at 6 weeks was not associated with severity of illness, age, or requirement for intensive care. Fatigue was the most common reported persistent symptom with a prevalence of 55.8%, followed by dyspnea (20%) and weight loss (16.7%). Female sex (odds ratio [OR] 2.4, 95% CI 1.03-5.58; P=.04) and steroid administration during hospital stay (OR 4.43, 95% CI 1.9-10.28; P=.001) were found to be significant risk factors for the presence of post-COVID-19 symptoms at 6 weeks as revealed by logistic regression analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Overall, 60.8% of inpatients treated for COVID-19 had post-COVID-19 symptoms at 6 weeks postdischarge from the hospital. The incidence of post-COVID-19 syndrome in the cohort did not significantly differ across the mild, moderate, and severe COVID-19 severity categories. Female sex and steroid administration during the hospital stay were identified as predictors of the persistence of post-COVID-19 symptoms at 6 weeks.</AbstractText><CopyrightInformation>&#xa9;Chithira V Nair, Merlin Moni, Fabia Edathadathil, Appukuttan A, Preetha Prasanna, Roshni Pushpa Raghavan, Dipu T Sathyapalan, Aveek Jayant. Originally published in JMIR Formative Research (https://formative.jmir.org), 18.04.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Chithira V</ForeName><Initials>CV</Initials><Identifier Source="ORCID">0000-0002-5000-6350</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Kochi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moni</LastName><ForeName>Merlin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1873-1488</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Kochi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edathadathil</LastName><ForeName>Fabia</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5168-2652</Identifier><AffiliationInfo><Affiliation>Department of Infection Control and Epidemiology, Amrita Institute of Medical Science and Research Centre, Kochi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>A</LastName><ForeName>Appukuttan</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4847-5518</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Kochi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasanna</LastName><ForeName>Preetha</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9299-6973</Identifier><AffiliationInfo><Affiliation>Department of Medical Administration, Amrita Institute of Medical Science and Research Centre, Kochi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pushpa Raghavan</LastName><ForeName>Roshni</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7496-0846</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy Practice, Amrita School of Pharmacy, Kochi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathyapalan</LastName><ForeName>Dipu T</ForeName><Initials>DT</Initials><Identifier Source="ORCID">0000-0003-1098-9900</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Kochi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayant</LastName><ForeName>Aveek</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3465-1229</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia, Critical Care and Pain, Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Form Res</MedlineTA><NlmUniqueID>101726394</NlmUniqueID><ISSNLinking>2561-326X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">follow-up</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 symptoms</Keyword><Keyword MajorTopicYN="N">postdischarge</Keyword><Keyword MajorTopicYN="N">prospective observational study</Keyword><Keyword MajorTopicYN="N">questionnaire</Keyword><Keyword MajorTopicYN="N">steroid</Keyword><Keyword MajorTopicYN="N">symptom monitoring</Keyword><Keyword MajorTopicYN="N">tertiary-care center</Keyword><Keyword MajorTopicYN="N">treatment</Keyword><Keyword MajorTopicYN="N">viral therapy</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>12</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36920842</ArticleId><ArticleId IdType="pmc">PMC10131721</ArticleId><ArticleId IdType="doi">10.2196/40028</ArticleId><ArticleId IdType="pii">v7i1e40028</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, Alijotas-Reig J, Zinserling V, Semenova N, Amital H, Shoenfeld Y. Covid-19 and autoimmunity. Autoimmun Rev. 2020 Aug;19(8):102597. doi: 10.1016/j.autrev.2020.102597. 
 
S1568-9972(20)30161-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102597</ArticleId><ArticleId IdType="pmc">PMC7289100</ArticleId><ArticleId IdType="pubmed">32535093</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8. 
 
S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Leth S, Gunst J, Mathiasen V, Hansen K, S&#xf8;gaard O, &#xd8;stergaard L, Jensen-Fangel S, Storgaard M, Agergaard J. Persistent symptoms in patients recovering from COVID-19 in Denmark. Open Forum Infect Dis. 2021 Apr;8(4):ofab042&#x2013;118. doi: 10.1093/ofid/ofab042. 
 
ofab042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab042</ArticleId><ArticleId IdType="pmc">PMC7928683</ArticleId><ArticleId IdType="pubmed">33875970</ArticleId></ArticleIdList></Reference><Reference><Citation>Nune A, Durkowski V, Titman A, Gupta L, Hadzhiivanov M, Ahmed A, Musat C, Sapkota HR. Incidence and risk factors of long COVID in the UK: a single-centre observational study. J R Coll Physicians Edinb. 2021 Dec;51(4):338&#x2013;343. doi: 10.4997/JRCPE.2021.405.</Citation><ArticleIdList><ArticleId IdType="doi">10.4997/JRCPE.2021.405</ArticleId><ArticleId IdType="pubmed">34882130</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi Z. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021 Mar 06;19(3):141&#x2013;154. doi: 10.1038/s41579-020-00459-7. 
 
10.1038/s41579-020-00459-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton R. Offline: COVID-19 is not a pandemic. Lancet. 2020 Sep 26;396(10255):874. doi: 10.1016/S0140-6736(20)32000-6. 
 
S0140-6736(20)32000-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32000-6</ArticleId><ArticleId IdType="pmc">PMC7515561</ArticleId><ArticleId IdType="pubmed">32979964</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19: NICE guideline NG188. National Institute for Health and Care Excellence. 2020.  [2022-01-26].  
 https://www.nice.org.uk/guidance/ng188
.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C, Wyller V, Moss-Morris R, Buchwald D, Crawley E, Hautvast J, Katz BZ, Knoop H, Little P, Taylor R, Wensaas KA, Lloyd AR. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect Dis. 2021 Oct;8(10):ofab440. doi: 10.1093/ofid/ofab440. 
 
ofab440</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Xu H, Jiang H, Wang L, Lu C, Wei X, Liu J, Xu S. Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM. 2020 Sep 01;113(9):657&#x2013;665. doi: 10.1093/qjmed/hcaa178. 
 
5842146</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa178</ArticleId><ArticleId IdType="pmc">PMC7313792</ArticleId><ArticleId IdType="pubmed">32442308</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021 Feb 01;4(2):e210830. doi: 10.1001/jamanetworkopen.2021.0830. 
 
2776560</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021 Apr 11;199(2):113&#x2013;119. doi: 10.1007/s00408-021-00423-z. 
 
10.1007/s00408-021-00423-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik S, Haldar SN, Soneja M, Mundadan NG, Garg P, Mittal A, Desai D, Trilangi PK, Chakraborty S, Begam NN, Bhattacharya B, Maher G, Mahishi N, Rajanna C, Kumar SS, Arunan B, Kirtana J, Gupta A, Patidar D, Kodan P, Sethi P, Ray A, Jorwal P, Kumar A, Nischal N, Sinha S, Biswas A, Wig N. Post COVID-19 sequelae: a prospective observational study from Northern India. Drug Discov Ther. 2021 Nov 21;15(5):254&#x2013;260. doi: 10.5582/ddt.2021.01093.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01093</ArticleId><ArticleId IdType="pubmed">34719599</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022 Jan 01;322(1):C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindstr&#xf6;m B, Eriksson M. Salutogenesis. J Epidemiol Community Health. 2005 Jun 01;59(6):440&#x2013;442. doi: 10.1136/jech.2005.034777. 
 
59/6/440</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.2005.034777</ArticleId><ArticleId IdType="pmc">PMC1757059</ArticleId><ArticleId IdType="pubmed">15911636</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao J, Shi L, Chen H, Wang X, Yang M, Yang J, Liu M, Yi X, Sun G. Containment strategy during the COVID-19 pandemic among three Asian low and middle-income countries. J Glob Health. 2022 May 21;12:05016. doi: 10.7189/jogh.12.05016. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05016</ArticleId><ArticleId IdType="pmc">PMC9123341</ArticleId><ArticleId IdType="pubmed">35596570</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021 Aug 21;58(5):297&#x2013;310. doi: 10.1080/10408363.2020.1860895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1860895</ArticleId><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Fronteira I, Sidat M, Magalh&#xe3;es JP, de Barros FPC, Delgado AP, Correia T, Daniel-Ribeiro CT, Ferrinho P. The SARS-CoV-2 pandemic: a syndemic perspective. One Health. 2021 Jun;12:100228. doi: 10.1016/j.onehlt.2021.100228. 
 
S2352-7714(21)00018-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.onehlt.2021.100228</ArticleId><ArticleId IdType="pmc">PMC7887445</ArticleId><ArticleId IdType="pubmed">33614885</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition  A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022 Apr;22(4):e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9. 
 
S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O'Connor RJ, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021 Feb;93(2):1013&#x2013;1022. doi: 10.1002/jmv.26368. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, Rasouli L, Zetkulic M, Balani B, Ogedegbe C, Bawa H, Berrol L, Qureshi N, Aschner JL. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020 Dec 11;15(12):e0243882. doi: 10.1371/journal.pone.0243882. 
 
PONE-D-20-25200</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med. 2021 May 4;8:653516. doi: 10.3389/fmed.2021.653516. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R, Rahman MM, Rassel MA, Monayem FB, Sayeed SKJB, Islam MS, Islam MM. Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021 Apr 8;16(4):e0249644. doi: 10.1371/journal.pone.0249644. 
 
PONE-D-21-02914</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249644</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0249644</ArticleId><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y, Zhang X, Cen Y, Wang B, Zhao S, Zhou Y, Hu B, Wang M, Liu Y, Miao H, Jones P, Ma X, He Y, Cao G, Cheng L, Li L. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw Open. 2021 Sep 01;4(9):e2127403. doi: 10.1001/jamanetworkopen.2021.27403. 
 
2784558</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira RMR, Freire de Carvalho J. Glucocorticoid-induced myopathy. Joint Bone Spine. 2011 Jan;78(1):41&#x2013;44. doi: 10.1016/j.jbspin.2010.02.025.S1297-319X(10)00089-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2010.02.025</ArticleId><ArticleId IdType="pubmed">20471889</ArticleId></ArticleIdList></Reference><Reference><Citation>Randomised Evaluation of COVID-19 Therapy (RECOVERY) ClinicalTrials.gov.  [2021-12-21].  
 https://clinicaltrials.gov/ct2/show/NCT04381936
.</Citation></Reference><Reference><Citation>Swartz M, Rock M, Wells S, Swartz M, Morales IS, Seashore J, Deer R. A retrospective study of Post-COVID Recovery Clinic's screening data to determine prevalence of frailty and pre-frailty among COVID-19 survivors. Arch Phys Med Rehab. 2022 Mar;103(3):e17. doi: 10.1016/j.apmr.2022.01.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2022.01.045</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskaran K, Rentsch CT, Hickman G, Hulme WJ, Schultze A, Curtis HJ, Wing K, Warren-Gash C, Tomlinson L, Bates CJ, Mathur R, MacKenna B, Mahalingasivam V, Wong A, Walker AJ, Morton CE, Grint D, Mehrkar A, Eggo RM, Inglesby P, Douglas IJ, McDonald HI, Cockburn J, Williamson EJ, Evans D, Parry J, Hester F, Harper S, Evans SJ, Bacon S, Smeeth L, Goldacre B. Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: a cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform. PLoS Med. 2022 Jan 25;19(1):e1003871. doi: 10.1371/journal.pmed.1003871. 
 
PMEDICINE-D-21-02562</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003871</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1003871</ArticleId><ArticleId IdType="pmc">PMC8789178</ArticleId><ArticleId IdType="pubmed">35077449</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali MA, Kamraju M. Re-imagining the new normal-the transformational lens of COVID-19. Bhopal, India: The Bhopal School of Social Sciences; 2020. A study on impact of covid-19 pandemic on unemployment in India; pp. 10&#x2013;61.</Citation></Reference><Reference><Citation>Yadav UN, Rayamajhee B, Mistry SK, Parsekar SS, Mishra SK. A syndemic perspective on the management of non-communicable diseases amid the COVID-19 pandemic in low- and middle-income countries. Front Public Health. 2020 Sep 25;8:508. doi: 10.3389/fpubh.2020.00508. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00508</ArticleId><ArticleId IdType="pmc">PMC7545493</ArticleId><ArticleId IdType="pubmed">33102414</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor M, Agrawal D, Ravi S, Roy A, Subramanian SV, Guleria R. Missing female patients: an observational analysis of sex ratio among outpatients in a referral tertiary care public hospital in India. BMJ Open. 2019 Aug 07;9(8):e026850. doi: 10.1136/bmjopen-2018-026850. 
 
bmjopen-2018-026850</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-026850</ArticleId><ArticleId IdType="pmc">PMC6687005</ArticleId><ArticleId IdType="pubmed">31391189</ArticleId></ArticleIdList></Reference><Reference><Citation>Nambiar A, Rana S, Rajagopal M. Serious health-related suffering and palliative care in South Asian countries. Curr Opin Support Palliat Care. 2021 Sep 01;15(3):169&#x2013;173. doi: 10.1097/SPC.0000000000000565.01263393-900000000-99289</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SPC.0000000000000565</ArticleId><ArticleId IdType="pubmed">34292186</ArticleId></ArticleIdList></Reference><Reference><Citation>Shagun. Shaji KA, Sahu PR, Khan MI, Mohan GR, Bhagirath  Myth of coverage: private insurance loopholes kept out-of-pocket expenses high for COVID-19 patients. Down to Earth. 2022. Jan 11,  [2022-01-12].  
 https://tinyurl.com/4r5ns6u9
.</Citation></Reference><Reference><Citation>Murthy RS. National Mental Health Survey of India 2015-2016. Indian J Psychiatry. 2017;59(1):21&#x2013;26. doi: 10.4103/psychiatry.IndianJPsychiatry_102_17. 
 
IJPsy-59-21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/psychiatry.IndianJPsychiatry_102_17</ArticleId><ArticleId IdType="pmc">PMC5419008</ArticleId><ArticleId IdType="pubmed">28529357</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Dashboard for Vaccine Equity. UNDP Data Futures.  [2022-01-02].  
 https://data.undp.org/vaccine-equity/
</Citation></Reference><Reference><Citation>Chakrabarti S, Shah R. Telepsychiatry in the developing world: Whither promised joy? Indian J Soc Psychiatry. 2016;32(3):273. doi: 10.4103/0971-9962.193200.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-9962.193200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim FA, Pahuja E, Dinakaran D, Manjunatha N, Kumar CN, Math SB. The future of telepsychiatry in India. Indian J Psychol Med. 2020 Oct 08;42(5 Suppl):112S&#x2013;117S. doi: 10.1177/0253717620959255. 
 
10.1177_0253717620959255</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0253717620959255?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1177/0253717620959255</ArticleId><ArticleId IdType="pmc">PMC7736745</ArticleId><ArticleId IdType="pubmed">33354056</ArticleId></ArticleIdList></Reference><Reference><Citation>Smartphone penetration rate in India from 2010 to 2020, with estimates until 2040. Statista.  [2022-01-02].  
 https://www.statista.com/statistics/1229799/india-smartphone-penetration-rate/
</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>